Acute effects of His bundle pacing versus left ventricular and right ventricular pacing on left ventricular function.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 17996519)

Published in Am J Cardiol on November 15, 2007

Authors

Luigi Padeletti1, Randy Lieberman, Jan Schreuder, Antonio Michelucci, Andrea Collella, Paolo Pieragnoli, Giuseppe Ricciardi, William Eastman, Sergio Valsecchi, Douglas A Hettrick

Author Affiliations

1: University of Florence, Florence, Italy.

Articles by these authors

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA (2003) 5.30

Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation (2012) 2.13

Incidence and predictors of heart failure hospitalization and death in permanent pacemaker patients: a single-centre experience over medium-term follow-up. Europace (2013) 2.03

Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation (2004) 1.90

Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation. Eur Heart J (2006) 1.82

Avoidance of right ventricular pacing in cardiac resynchronization therapy improves right ventricular hemodynamics in heart failure patients. J Cardiovasc Electrophysiol (2007) 1.75

Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace (2011) 1.64

Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias. Am Heart J (2007) 1.60

Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J Am Coll Cardiol (2006) 1.49

Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol (2005) 1.49

A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy. Pacing Clin Electrophysiol (2008) 1.48

Epicardial ganglionated plexus stimulation decreases postoperative inflammatory response in humans. Heart Rhythm (2012) 1.46

Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients. Eur Heart J (2004) 1.46

[Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society]. G Ital Cardiol (Rome) (2010) 1.41

Real-time 3-dimensional transthoracic echocardiography improves the diagnosis of isolated ventricular noncompaction. J Ultrasound Med (2007) 1.39

Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation--ease of use, acceptance, and organizational implications. Pacing Clin Electrophysiol (2008) 1.37

Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol (2003) 1.22

Mechanical function of the left atrium: new insights based on analysis of pressure-volume relations and Doppler echocardiography. Anesthesiology (2003) 1.20

Remote monitoring of patients with biventricular defibrillators through the CareLink system improves clinical management of arrhythmias and heart failure episodes. J Interv Card Electrophysiol (2008) 1.17

Intrathoracic impedance and pulmonary wedge pressure for the detection of heart failure deterioration. Europace (2010) 1.17

Accuracy of atrial tachyarrhythmia detection in implantable devices with arrhythmia therapies. Pacing Clin Electrophysiol (2004) 1.15

Alterations in wall shear stress predict sites of neointimal hyperplasia after stent implantation in rabbit iliac arteries. Am J Physiol Heart Circ Physiol (2005) 1.14

Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail (2011) 1.13

Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol (2009) 1.12

P wave assessment: state of the art update. Card Electrophysiol Rev (2002) 1.09

Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry. J Am Coll Cardiol (2008) 1.07

Myocardial perfusion imaging using gated SPECT in heart failure patients undergoing cardiac resynchronization therapy. J Nucl Med (2004) 1.07

Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. J Card Fail (2009) 1.05

Echocardiographic examination of atrioventricular and interventricular delay optimization in cardiac resynchronization therapy. Am J Cardiol (2005) 1.03

Prediction of response to cardiac resynchronization therapy: the selection of candidates for CRT (SCART) study. Pacing Clin Electrophysiol (2006) 1.01

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation (2011) 0.99

Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin Electrophysiol (2007) 0.99

Follow-up of CRT-ICD: implications for the use of remote follow-up systems. Data from the InSync ICD Italian Registry. Pacing Clin Electrophysiol (2008) 0.97

Three-dimensional computational fluid dynamics modeling of alterations in coronary wall shear stress produced by stent implantation. Ann Biomed Eng (2003) 0.96

Incremental value of larger interventricular conduction time in improving cardiac resynchronization therapy outcome in patients with different QRS duration. J Cardiovasc Electrophysiol (2014) 0.95

Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. Pacing Clin Electrophysiol (2003) 0.94

Limited thoracotomy as a second choice alternative to transvenous implant for cardiac resynchronisation therapy delivery. Eur Heart J (2004) 0.92

Temporal variation in optimal atrioventricular and interventricular delay during cardiac resynchronization therapy. J Card Fail (2006) 0.92

Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. Int J Cardiol (2006) 0.92

Circumferential vascular deformation after stent implantation alters wall shear stress evaluated with time-dependent 3D computational fluid dynamics models. J Appl Physiol (1985) (2004) 0.92

Stent design properties and deployment ratio influence indexes of wall shear stress: a three-dimensional computational fluid dynamics investigation within a normal artery. J Appl Physiol (1985) (2004) 0.92

Assessment of a remote monitoring system for implantable cardioverter defibrillators. J Telemed Telecare (2008) 0.91

Clinical profile of recurrent community-acquired pneumonia in children. BMC Pulm Med (2013) 0.91

Acute hemodynamic effect of left ventricular endocardial pacing in cardiac resynchronization therapy: assessment by pressure-volume loops. Circ Arrhythm Electrophysiol (2012) 0.90

Cost-utility analysis of the EVOLVO study on remote monitoring for heart failure patients with implantable defibrillators: randomized controlled trial. J Med Internet Res (2013) 0.90

Reactive oxygen species modulate coronary wall shear stress and endothelial function during hyperglycemia. Am J Physiol Heart Circ Physiol (2003) 0.89

Transvenous retrieval of foreign objects lost during cardiac device implantation or revision: a 10-year experience. Pacing Clin Electrophysiol (2013) 0.89

Hemodynamic sensor in cardiac implantable electric devices: the endocardial accelaration technology. J Healthc Eng (2013) 0.89

Effect of bipolar electrode spacing on phrenic nerve stimulation and left ventricular pacing thresholds: an acute canine study. Circ Arrhythm Electrophysiol (2012) 0.88

Long-term survival in patients treated with cardiac resynchronization therapy: a 3-year follow-up study from the InSync/InSync ICD Italian Registry. Pacing Clin Electrophysiol (2006) 0.88

Automatic management of left ventricular stimulation: hints for technologic improvement. Pacing Clin Electrophysiol (2009) 0.88

Single-operator experience with a mechanical approach for removal of pacing and implantable defibrillator leads. Europace (2009) 0.88

Axial stent strut angle influences wall shear stress after stent implantation: analysis using 3D computational fluid dynamics models of stent foreshortening. Biomed Eng Online (2005) 0.87

Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. J Appl Physiol (1985) (2009) 0.87

Intrathoracic and ventricular impedances are associated with changes in ventricular volume in patients receiving defibrillators for CRT. Pacing Clin Electrophysiol (2009) 0.86

Dual-site left ventricular cardiac resynchronization therapy. Am J Cardiol (2008) 0.86

High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm (2005) 0.86

CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy. Europace (2013) 0.85

Stent implantation alters coronary artery hemodynamics and wall shear stress during maximal vasodilation. J Appl Physiol (1985) (2002) 0.85

Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure. Cardiol J (2009) 0.84

Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias in myotonic dystrophy type 1. J Cardiovasc Electrophysiol (2006) 0.84

Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Am J Cardiol (2007) 0.84

A perspective on atrioventricular delay optimization in patients with a dual chamber pacemaker. Pacing Clin Electrophysiol (2004) 0.84

Utility of a new left ventricular asynchrony index as a predictor of reverse remodelling after cardiac resynchronization therapy. Eur Heart J (2006) 0.84

Automatic adjustment of stimulation output in resynchronization therapy: impact and effectiveness in clinical practice. Europace (2011) 0.83

Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy. BMC Infect Dis (2010) 0.83

Is a dual-sensor pacemaker appropriate in patients with sino-atrial disease? Results from the DUSISLOG study. Pacing Clin Electrophysiol (2006) 0.83

Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial. Am Heart J (2008) 0.83

Atrial fibrillation and cardiac resynchronization therapy: the MASCOT study. Europace (2004) 0.83

How to test mode switching in pacemakers implanted in patients: the MOST study. Pacing Clin Electrophysiol (2002) 0.83

Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure. Eur J Echocardiogr (2006) 0.82

Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale. Am Heart J (2008) 0.82

Long-term reduction of atrial tachyarrhythmia recurrences in patients paced for bradycardia-tachycardia syndrome. Heart Rhythm (2005) 0.82

Results of the SCART study: selection of candidates for cardiac resynchronisation therapy. J Cardiovasc Med (Hagerstown) (2007) 0.82

Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. J Rheumatol (2011) 0.81

Relation of inflammatory status to major adverse cardiac events and reverse remodeling in patients undergoing cardiac resynchronization therapy. J Card Fail (2007) 0.81

Metabolomic does not predict response to cardiac resynchronization therapy in patients with heart failure. J Cardiovasc Med (Hagerstown) (2014) 0.81

Microvolt T-wave alternans as predictor of electrophysiological testing results in professional competitive athletes. Ann Noninvasive Electrocardiol (2004) 0.81